Decreased drug accumulation is often associated with resistance of tumour cells to anticancer drugs and frequently involves overexpression of drug efflux proteins, P-glycoprotein (Pgp170) being the most common pump related to drug resistance (Germann, 1996; Gottesman et al, 2002). Here, ABCB1 is linked to neoplasm.